Oral and Poster Presentations to Highlight Clinical Data for I/ONTAK (E7777) Study in Relapsed or Refractory Cutaneous T-cell Lymphoma on December 11, 2022 CRANFORD, N.J., Nov. 9, 2022...

U.S. Special Presidential Envoy for Climate John Kerry, the Bezos Earth Fund, and The Rockefeller Foundation announced a process to design an Energy Transition Accelerator (ETA) with the potential...

AbbVie (NYSE: ABBV) will participate in the 4th Annual Wolfe Research Healthcare Conference on Tuesday, November 15, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive...

Research team presenting on value of telerehabilitation and advances in patient-reported outcomes measurement for patients with dizziness and balance impairments PITTSBURGH, Nov. 9, 2022...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the poster, titled...